Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Azd0543

Phase 1

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Human Metapneumovirus InfectionRecruiting

Human Metapneumovirus InfectionPhase 1

Recruiting

Timeline

Expected Milestones

Q4 2027

Phase 1Recruiting

Human Metapneumovirus Infection

NCT07824622

Clinical

Trials by Indication[1]

Human Metapneumovirus Infection1 trial

A Phase I, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Pharmacokinetics of AZD0543 in Healthy Adults

Recruiting· AstraZeneca logo

AstraZeneca·Phase 1·NCT07824622·144 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Azd0543. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Azd0543. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — AstraZeneca company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 1[1]
Company: AstraZeneca

Related News